NCT01935856View on ClinicalTrials.gov

Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Hyperparathyroidism
Interventions
DRUG

KHK7580

Oral administration

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin, Tokyo

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT01935856 - Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis | Biotech Hunter | Biotech Hunter